Mylan's EpiPen Profit 60% Higher Than Told to Congress

Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.

from WSJ.com: US Business http://ift.tt/2cXbr8P
via IFTTT